These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6208933)

  • 1. Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias.
    Salama A; Mueller-Eckhardt C; Kissel K; Pralle H; Seeger W
    Br J Haematol; 1984 Nov; 58(3):525-31. PubMed ID: 6208933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia.
    Salama A; Mueller-Eckhardt C
    N Engl J Med; 1985 Aug; 313(8):469-74. PubMed ID: 4022080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two types of nomifensine-induced immune haemolytic anaemias: drug-dependent sensitization and/or autoimmunization.
    Salama A; Mueller-Eckhardt C
    Br J Haematol; 1986 Nov; 64(3):613-20. PubMed ID: 3790448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demonstration of drug-specific IgE and IgG antibodies using RIA: clinical importance as shown with nomifensin (Alival)].
    Wälti M; Neftel K; Cohen M; de Weck AL; Perisić M
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1865-7. PubMed ID: 6676940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic determinants responsible for the reactions of drug-dependent antibodies with blood cells.
    Salama A; Santoso S; Mueller-Eckhardt C
    Br J Haematol; 1991 Aug; 78(4):535-9. PubMed ID: 1716956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from nomifensine.
    Lancet; 1988 Nov; 2(8619):1059-60. PubMed ID: 2903284
    [No Abstract]   [Full Text] [Related]  

  • 7. Massive intravascular haemolysis during treatment of nomifensine.
    Lylloff K; Jersild C; Bacher T; Slot O
    Lancet; 1982 Jul; 2(8288):41. PubMed ID: 6123767
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-nomifensine antibody causing immune hemolytic anemia and renal failure.
    Habibi B; Cartron JP; Bretagne M; Rouger P; Salmon C
    Vox Sang; 1981 Feb; 40(2):79-84. PubMed ID: 7233885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine.
    Salama A; Mueller-Eckhardt C
    Blood; 1986 Dec; 68(6):1285-8. PubMed ID: 3096400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomifensine-induced immune hemolytic anemia and posttransfusion purpura in the same patient.
    Mueller-Eckhardt C; Allolio B; Salama A; Kiefel V; Deuss U
    Transfusion; 1987; 27(3):250-2. PubMed ID: 3590288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up study on 24 patients with nomifensine-induced immune haemolytic anaemia.
    Giers G; Salama A; Mueller-Eckhardt C
    Transfus Med; 1991 Jun; 1(2):115-9. PubMed ID: 9259837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex markers in patients with nomifensine-induced immune hemolytic anemia.
    Mueller-Eckhardt G; Giers G; Salama A; Schendel DJ; Fass G; Mueller-Eckhardt C
    Vox Sang; 1988; 54(1):59-61. PubMed ID: 3348023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies.
    Salama A; Kroll H; Wittmann G; Mueller-Eckhardt C
    Br J Haematol; 1996 Dec; 95(4):640-4. PubMed ID: 8982039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature.
    Seltsam A; Salama A
    Intensive Care Med; 2000 Sep; 26(9):1390-4. PubMed ID: 11089773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis.
    Salama A; Göttsche B; Mueller-Eckhardt C
    Br J Haematol; 1991 Apr; 77(4):546-9. PubMed ID: 2025580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute immune intravascular hemolysis due to hydrochlorothiazide.
    Garratty G; Houston M; Petz LD; Webb M
    Am J Clin Pathol; 1981 Jul; 76(1):73-8. PubMed ID: 7258154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nomifensin-induced immune haemolytic anaemias (author's transl)].
    Eckstein R; Riess H; Sauer H; Mempel W
    Klin Wochenschr; 1981 Jun; 59(11):567-9. PubMed ID: 7265812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil.
    Yürek S; Riess H; Kreher S; Dörken B; Salama A
    Transfus Med; 2010 Aug; 20(4):265-8. PubMed ID: 20456688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal intravascular immune hemolysis induced by hydrochlorothiazide.
    Beck ML; Cline JF; Hardman JT; Racela LS; Davis JW
    Am J Clin Pathol; 1984 Jun; 81(6):791-4. PubMed ID: 6731360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemolytic 'efficiency' of C5b-9 complexes in drug-induced immune haemolysis: role of cellular C5b-9 distribution.
    Salama A; Mueller-Eckhardt C; Boschek B; Bhakdi S
    Br J Haematol; 1987 Feb; 65(2):217-22. PubMed ID: 2950920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.